In vitro assays and techniques utilized in anticancer drug discovery

MK Ediriweera, KH Tennekoon… - Journal of Applied …, 2019 - Wiley Online Library
Abstract Development of a cancer is a multistep process and six major hallmarks of cancer
that are known to control malignant transformation have been described. Anticancer drug …

[HTML][HTML] Antiproliferative activity of thiazole and oxazole derivatives: A systematic review of in vitro and in vivo studies

NY Guerrero-Pepinosa, MC Cardona-Trujillo… - Biomedicine & …, 2021 - Elsevier
Thiazole and oxazole are compounds with a heterocyclic nucleus that have attracted the
attention of medicinal chemistry due to the great variety of biological activities that they …

Synthesis, DFT study, molecular docking and drug‐likeness analysis of the new Hydrazine‐1‐carbothioamide, triazole and thiadiazole derivatives: potential inhibitors …

İ Çapan, S Servi, İ Yıldırım, Y Sert - ChemistrySelect, 2021 - Wiley Online Library
In this research, the new hydrazine‐1‐carbothioamides (IC32 and IC34) having
unsubstituted benzimidazole skeleton were converted to 1, 2, 4‐triazole derivatives (IC42 …

[HTML][HTML] Comparative study of the synthetic approaches and biological activities of the bioisosteres of 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles over the past decade

RM El-Masry, HH Kadry, AT Taher, SM Abou-Seri - Molecules, 2022 - mdpi.com
The bioisosteres of 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles are well-known
pharmacophores for many medicinally important drugs. Throughout the past 10 years, 1, 3, 4 …

[HTML][HTML] Design, synthesis and evaluation of novel 1, 2, 4-triazole derivatives as promising anticancer agents

L Emami, S Sadeghian, A Mojaddami, S Khabnadideh… - BMC chemistry, 2022 - Springer
Herein, we reported the synthesis of nineteen novel 1, 2, 4-triazole derivatives including 1, 3-
diphenyl-2-(1H-1, 2, 4-triazol-1-yl) propan-1-ones (7a-e), 1-(1, 3-diphenylpropan-2-yl)-1 H-1 …

1, 3, 4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities

MAA Fathi, AA Abd El-Hafeez, D Abdelhamid… - Bioorganic …, 2019 - Elsevier
Abstract A new series of 1, 3, 4-oxadiazole/chalcone hybrids was designed, synthesized,
identified with different spectroscopic techniques and biologically evaluated as inhibitors of …

225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models

R Garg, KJH Allen, W Dawicki… - Cancer …, 2021 - Wiley Online Library
Purpose Despite the availability of new drugs, many patients with acute myeloid leukemia
(AML) do not achieve remission and outcomes remain poor. Venetoclax is a promising new …

Synthesis of new bioactive indolyl-1, 2, 4-triazole hybrids as dual inhibitors for EGFR/PARP-1 targeting breast and liver cancer cells

MF Youssef, MS Nafie, EE Salama, ATA Boraei… - ACS …, 2022 - ACS Publications
Cancer is the most severe disease worldwide. Every year, tens of millions of people are
diagnosed with cancer, and over half of those people will ultimately die from the disease …

Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach

MJ Horgan, L Zell, B Siewert, H Stuppner… - Journal of Chemical …, 2023 - ACS Publications
Due to their potential as leads for various therapeutic applications, including as antimitotic
and antiparasitic agents, the development of tubulin inhibitors offers promise for drug …

Novel oxadiazole-thiadiazole derivatives: synthesis, biological evaluation, and in silico studies

AE Evren, D Nuha, S Dawbaa… - Journal of …, 2024 - Taylor & Francis
In the search for new anticancer agents, we synthesized a new series of thiazole derivatives
carried on thiadiazole-oxadiazole hybrid. Final compounds (5a–5i) were analyzed via 1H …